keyword
https://read.qxmd.com/read/33140098/radon-in-mines-of-kryvyi-rih-iron-ore-basin-in-ukraine
#1
JOURNAL ARTICLE
O Molchanov, A Podrezov, K Brechko, Y Soroka, L Ishchenko
The first studies of radiation exposure in old mines of Kryvyi Rih Iron Ore Basin (Kryvbas) began relatively recently, about 20 years ago. The results of these studies have shown that the problem of radon is present in the major part of the Basin mines. In 6 of 8 mines tested, an excess of radiation safety standards for the equilibrium equivalent decay products concentration (EEC) of Radon-222 was observed. According to the sum of the main measured parameters of radiation situation, a preliminary assessment of doses to underground workers was made and a classification of the Basin mines according to radiation danger was developed...
November 27, 2020: Radiation Protection Dosimetry
https://read.qxmd.com/read/33132058/ultra-central-thoracic-re-irradiation-using-10-fraction-stereotactic-body-radiotherapy-for-recurrent-non-small-cell-lung-cancer-tumors-preliminary-toxicity-and-efficacy-outcomes
#2
JOURNAL ARTICLE
Sumit Sood, Rohit Ganju, Xinglei Shen, Mindi Ten Napel, Fen Wang
BACKGROUND: We report our clinical outcomes of patients with recurrent non-small-cell lung cancer (NSCLC) tumors with ultra-central (UC) location treated with hypofractionated 10-fraction stereotactic body radiotherapy (hSBRT) in the context of thoracic re-irradiation. PATIENTS AND METHODS: This study was conducted from 2009 to 2017 on 20 patients with recurrent NSCLC from previous thoracic radiation treatment who underwent hSBRT to 21 total UC located recurrent tumors...
May 2021: Clinical Lung Cancer
https://read.qxmd.com/read/33131539/cardiovascular-and-pulmonary-challenges-after-treatment-of-childhood-cancer
#3
REVIEW
Henk Visscher, Maria Otth, E A M Lieke Feijen, Paul C Nathan, Claudia E Kuehni
Childhood cancer survivors are at risk for developing cardiovascular disease and pulmonary disease related to cancer treatment. This might not become apparent until many years after treatment and varies from subclinical to life-threatening disease. Important causes are anthracyclines and radiotherapy involving heart, head, or neck for cardiovascular disease, and bleomycin, busulfan, nitrosoureas, radiation to the chest, and lung or chest surgery for pulmonary disease. Most effects are dose dependent, but genetic risk factors have been discovered...
December 2020: Pediatric Clinics of North America
https://read.qxmd.com/read/33130941/pre-treatment-with-bifidobacterium-infantis-and-its-specific-antibodies-enhance-targeted-radiosensitization-in-a-murine-model-for-lung-cancer
#4
JOURNAL ARTICLE
Juan Yang, ZhouXue Wu, Yao Chen, ChuanFei Hu, Dong Li, Yue Chen, Saber Imani, QingLian Wen, ShaoZhi Fu, JingBo Wu
PURPOSE: The hypoxic microenvironments of solid tumours are complex and reduce the susceptibility of cancer cells to chemo- and radiotherapy. Conventional radiosensitisers have poor specificity, unsatisfactory therapeutic effects, and significant side effects. Anaerobic bacteria colonise and destroy hypoxic areas of the tumour and consequently enhance the effects of radiation. METHODS: In this study, we treated a Lewis lung carcinoma transplant mouse model with Bifidobacterium infantis (Bi) combined with its specific monoclonal antibody (mAb) and radiotherapy (RT) to investigate its ability to radiosensitise the tumour...
February 2021: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/33130698/-interstitial-pneumonia-caused-by-olaparib-during-treatment-of-breast-cancer-a-case-report
#5
JOURNAL ARTICLE
Haruna Suzuki, Tomohiro Oshino, Kanako Hagio, Takashi Takeshita, Hiroko Yamashita
The characteristic adverse events of olaparib, a PARP inhibitor, are nausea, vomiting, and anemia, and interstitial pneumonia is rarely reported. We report a case of interstitial pneumonia following the treatment of a metastatic breast cancer with olaparib. The patient was a 34-year-old woman. In March 2018, she was diagnosed with stage Ⅳ breast cancer(multiple lung metastases). She was treated with epirubicin and cyclophosphamide followed by paclitaxel. In November 2018, brain and spinal cord metastases were detected, and she was treated with radiation...
September 2020: Gan to Kagaku Ryoho. Cancer & Chemotherapy
https://read.qxmd.com/read/33127337/who-benefits-the-most-from-adjuvant-durvalumab-after-chemoradiotherapy-for-non-small-cell-lung-cancer-an-exploratory-analysis
#6
JOURNAL ARTICLE
Nitin Ohri, Balazs Halmos, William R Bodner, Haiying Cheng, Madhur K Garg, Rasim Gucalp, Chandan Guha
PURPOSE: Adjuvant durvalumab is now recommended for most patients with locally advanced non-small cell lung cancer after concurrent chemoradiotherapy. Herein, we explore the clinical factors that may be associated with the benefit from adjuvant durvalumab. METHODS AND MATERIALS: Patients with non-small cell lung cancer who were treated with definitive concurrent chemoradiotherapy at our institution between August 2013 and May 2019 were included in this analysis...
March 2021: Practical Radiation Oncology
https://read.qxmd.com/read/33127293/investigation-of-approaches-for-internal-target-volume-definition-using-4-dimensional-computed-tomography-in-stereotactic-body-radiotherapy-of-lung-cancer
#7
JOURNAL ARTICLE
Canan Koksal, Nazmiye Donmez Kesen, Murat Okutan, Sule Karaman, Nergiz Dagoglu Sakin, Hatice Bilge
The present study was undertaken to investigate the suitability of alternative internal target volume (ITV) delineation strategies based on maximum intensity projection (MIP), average intensity projection (AIP), 2 extreme phases and 4 phases images relative to the ITV10phase in stereotactic body radiation therapy (SBRT) for lung cancer. The 4-dimensional computed tomography (4DCT) data of 15 lung cancer patients treated with SBRT in our clinic were used. Five different ITVs were generated as follows: merging GTVs from 10 phases (ITV10Phase ); merging GTVs from 2 extreme phases (0%, 50%) (ITV2Phase ); merging GTVs from 4 phases (0%, 20%, 50%, and 70%) (ITV4Phase ); delineating GTV on MIP (ITVMIP ), and delineating GTV on AIP (ITVAIP )...
July 2021: Medical Dosimetry: Official Journal of the American Association of Medical Dosimetrists
https://read.qxmd.com/read/33125182/case-of-epithelioid-hemangioendothelioma-occurring-in-the-postradiation-setting-for-breast-cancer
#8
JOURNAL ARTICLE
Elan Hahn, Brendan C Dickson, Abha A Gupta, Sharon Nofech-Mozes
Epithelioid hemangioendothelioma (EHE) is a rare malignant vascular tumor, which is typically characterized by recurrent fusion genes. EHEs most commonly occur in the lung, liver, bone, and internal organs. EHE has rarely been reported to occur in the post-radiotherapeutic setting, the breast site or in association with breast cancer. The differential diagnosis for radiation-associated vascular lesions of the breast is classically limited to atypical vascular lesion and angiosarcoma and does not include EHE...
February 2021: Genes, Chromosomes & Cancer
https://read.qxmd.com/read/33125142/mir%C3%A2-7-sp1-tp53bp1-axis-may-play-a-pivotal-role-in-nsclc-radiosensitivity
#9
JOURNAL ARTICLE
Genyan Guo, Lingling Li, Guanchu Song, Jie Wang, Ying Yan, Yuxia Zhao
MicroRNA‑7 (miR‑7) has been identified as a tumor suppressor in non‑small cell lung cancer (NSCLC) and a radiosensitivity regulator. Numerous studies have revealed that specific protein 1 (SP1) plays a critical role in the tumorigenesis of various types of cancers and regulates radiosensitivity and tumor suppressor p53‑binding protein 1 (TP53BP1), which plays an essential role in DNA repair. However, it is not clear whether miR‑7 has a regulatory effect on SP1 and TP53BP1 in NSCLC. In the present study it was revealed that miR‑7 directly binds to the 3'UTR of SP1, thereby suppressing SP1 expression to regulate radiosensitivity...
October 23, 2020: Oncology Reports
https://read.qxmd.com/read/33124505/curcumin-inhibits-the-migration-and-invasion-of-non-small-cell-lung-cancer-cells-through-radiation-induced-suppression-of-epithelial-mesenchymal-transition-and-soluble-e-cadherin-expression
#10
JOURNAL ARTICLE
Xinzhou Deng, Chunli Chen, Feng Wu, Li Qiu, Qing Ke, Renhuang Sun, Qiwen Duan, Ming Luo, Zhiguo Luo
Radiotherapy has been reported to cause cancer metastasis. Thus, a new strategy for radiotherapy must be developed to avoid this side effect. A549 cells were exposed to radiation to induce an epithelial-mesenchymal transition (EMT) cell model. Real-time PCR and western blotting were used to detect mRNA and protein expression levels, and Transwell invasion and wound healing assays were used to detect cell migration and invasion. ELISA was used to detect soluble E-cadherin (sE-cad) secretion. siRNA was used to silence MMP9 expression...
January 2020: Technology in Cancer Research & Treatment
https://read.qxmd.com/read/33123429/talaromycosis-in-a-lung-cancer-patient-a-rare-case
#11
Rosario Ching-López, Sara Rodríguez Pavón
Emergent fungal infections are rare conditions that frequently cause death. Talaromycosis is a fungal infection caused by Talaromyces sp. that is predominantly prevalent in patients with acquired immunodeficiency syndrome caused by human immunodeficiency virus infection, but in recent years we have noticed increasing reports of cases in people with other underlying conditions. We report a case of talaromycosis in a Stage IV non-small cell lung cancer female patient undergoing whole brain radiation therapy who presented to us with increasing dyspnea, cough and fever...
September 23, 2020: Curēus
https://read.qxmd.com/read/33121520/prognostic-value-of-pd-l1-expression-in-patients-with-unresectable-stage-iii-non-small-cell-lung-cancer-treated-with-chemoradiotherapy
#12
JOURNAL ARTICLE
Martina Vrankar, Izidor Kern, Karmen Stanic
BACKGROUND: Expression of PD-L1 is the most investigated predictor of benefit from immune checkpoint blockade in advanced NSCLC but little is known about the association of PD-L1 expression and clinicopathological parameters of patients with unresectable stage III NSCLC. METHODS: National registry data was searched for medical records of consecutive inoperable stage III NSCLC patients treated with ChT and RT from January 2012 to December 2017. Totally 249 patients were identified that met inclusion criteria and of those 117 patients had sufficient tissue for PD-L1 immunohistochemical staining...
October 29, 2020: Radiation Oncology
https://read.qxmd.com/read/33120031/significance-of-thoron-measurements-in-indoor-environment
#13
JOURNAL ARTICLE
R C Ramola, Mukesh Prasad
Radon, 222 Rn, is the major contributor to natural radiation in human environment. The exposure of high radon is known as one of the causative factors of lung cancer. Though thoron, 220 Rn, has been a matter of study in atmospheric science, but it was often neglected compared to radon. It was considered that the amount of thoron in the environment is less than that of radon. However, recent studies show that thoron and its progeny sometime contribute significantly to the radiation dose in residential buildings...
October 26, 2020: Journal of Environmental Radioactivity
https://read.qxmd.com/read/33119939/a-simple-dosimetric-approach-to-spatially-fractionated-grid-radiation-therapy-using-the-multileaf-collimator-for-treatment-of-breast-cancers-in-the-prone-position
#14
JOURNAL ARTICLE
Natasha L Murphy, Rino Philip, Matt Wozniak, Brian H Lee, Eric D Donnelly, Hualin Zhang
The purpose of this study was to explore the treatment planning methods of spatially fractionated radiation therapy (SFRT), commonly referred to as GRID therapy, in the treatment of breast cancer patients using multileaf collimator (MLC) in the prone position. A total of 12 patients with either left or right breast cancer were retrospectively chosen. The computed tomography (CT) images taken for the whole breast external beam radiation therapy (WB-EBRT) were used for GRID therapy planning. Each GRID plan was made by using two portals and each portal had two fields with 1-cm aperture size...
October 29, 2020: Journal of Applied Clinical Medical Physics
https://read.qxmd.com/read/33119806/successful-treatment-of-gastric-cancer-after-complete-response-of-lung-cancer-by-nivolumab-a-case-report
#15
JOURNAL ARTICLE
Shunji Endo, Yoshinori Fujiwara, Koji Kurose, Masaharu Higashida, Hisako Kubota, Yuko Okamoto, Shumei Mineta, Hironori Tanaka, Toshimasa Okada, Atsushi Tsuruta, Takashi Akiyama, Toru Oga, Tomio Ueno
BACKGROUND: Nivolumab is effective for gastric cancer and lung cancer, but complete response is rare. We experienced a case of synchronous gastric cancer and lung cancer who was treated by nivolumab and laparoscopic gastrectomy. CASE PRESENTATION: A 63-year-old male consulted our institution and was found to have gastric cancer cT1(SM)N0M0 Stage IA and lung cancer cT2N2M1(PUL) Stage IV. He received eight chemotherapy treatments plus radiation, but the lung disease remained progressive...
October 29, 2020: Surgical Case Reports
https://read.qxmd.com/read/33117018/clinical-outcomes-of-proton-beam-therapy-for-ground-glass-opacity-type-lung-cancer
#16
JOURNAL ARTICLE
Ichiro Nagata, Takashi Ogino, Takeshi Arimura, Takashi Yoshiura
PURPOSE: Surgery is the standard treatment for early-stage non-small cell lung cancer (NSCLC), including ground-glass opacity (GGO)-type lung cancer. However, some patients are inoperable or refuse to undergo surgery. To explore whether proton beam therapy (PBT) can be an alternative to surgical resection in these patients, this study aimed to examine the retrospective treatment outcomes of patients with GGO-type lung cancer who underwent PBT. PATIENTS AND METHODS: Patients with stage I NSCLC and GGOs who underwent PBT at the Medipolis Proton Therapy and Research Center (Kagoshima, Japan) between April 2011 and September 2015 were included...
2020: Lung Cancer: Targets and Therapy
https://read.qxmd.com/read/33116824/sparing-organs-at-risk-with-simultaneous-integrated-boost-volumetric-modulated-arc-therapy-for-locally-advanced-non-small-cell-lung-cancer-an-automatic-treatment-planning-study
#17
JOURNAL ARTICLE
Daquan Wang, Jiayun Chen, Xiaodong Zhang, Tao Zhang, Luhua Wang, Qinfu Feng, Zongmei Zhou, Jianrong Dai, Nan Bi
Background: The technique of simultaneous integrated boost volumetric modulated arc therapy (SIB-VMAT) has been widely used in locally advanced non-small cell lung cancer; however, its dosimetric advantages are seldom reported. This study aimed to quantify dosimetric advantages of SIB-VMAT. Methods: Forty patients with stage III non-small cell lung cancer in our hospital were retrospectively included. SIB-VMAT and conventional VMAT (C-VMAT) plans were generated for every patient using the automatic treatment planning system...
2020: Cancer Management and Research
https://read.qxmd.com/read/33115687/stereotactic-body-radiation-therapy-for-mediastinal-and-hilar-lymph-node-metastases
#18
JOURNAL ARTICLE
Jeevin Shahi, Ian Poon, Yee C Ung, May Tsao, Georg A Bjarnason, Nauman H Malik, Liying Zhang, Alexander V Louie, Patrick Cheung
PURPOSE: Stereotactic body radiation therapy (SBRT) to metastatic mediastinal and hilar lymphadenopathy (MHL) is challenging owing to the proximity of centrally located organs-at-risk. As limited data exist on the safety and efficacy of SBRT for MHL, a retrospective review of clinical outcomes was conducted from a large academic center. METHODS AND MATERIALS: Eligible patients received SBRT to MHL between 2014 to 2019 for the following indications: oligometastases, oligoprogression, or local control of a dominant area of progression...
March 1, 2021: International Journal of Radiation Oncology, Biology, Physics
https://read.qxmd.com/read/33112561/scorpion-and-frog-organ-lysates-are-potential-source-of-antitumour-activity
#19
JOURNAL ARTICLE
Morhanavallee Soopramanien, Naveed Ahmed Khan, Sumayah Abdelnasir Osman Abdalla, K Sagathevan, Ruqaiyyah Siddiqui
OBJECTIVES: It is noteworthy that several animal species are known to withstand high levels of radiation, and are exposed to heavy metals but rarely been reported to develop cancer. For example, the scorpion has been used as folk medicine in ancient civilizations of Iran and China, while amphibian skin is known to possess medicinal properties. Here, we elucidated the anti-tumour activity of the scorpion (Uropygi) and frog (Lithobates catesbeianus). MATERIALS AND METHODS: Animals were procured and their organ lysates and sera were prepared and tested against Michigan Cancer Foundation-7 breast cancer (MCF-7), prostate cancer (PC3), Henrietta Lacks cervical cancer (HeLa), and normal human keratinocyte cells...
October 1, 2020: Asian Pacific Journal of Cancer Prevention: APJCP
https://read.qxmd.com/read/33110481/efavirenz-induces-dna-damage-response-pathway-in-lung-cancer
#20
JOURNAL ARTICLE
Rahaba Marima, Rodney Hull, Zodwa Dlamini, Clement Penny
The cell-cycle related genes are potential gene targets in understanding the effects of efavirenz (EFV) in lung cancer. The present study aimed at investigating the expression changes of cell-cycle related genes in response to EFV drug treatment in human non-small cell lung carcinoma (A549) and normal lung fibroblast (MRC-5) cells. The loss in nuclear integrity in response to EFV was detected by 4', 6-diamidino-2-phenylindole (DAPI) staining. Gene expression profiling was performed using human cell cycle PathwayFinder RT2 Profiler™ PCR Array...
October 13, 2020: Oncotarget
keyword
keyword
115171
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.